TWD 675.0
(3.05%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 5 Billion TWD | -34.07% |
2022 | 7.59 Billion TWD | 241.19% |
2021 | 2.22 Billion TWD | -22.73% |
2020 | 2.88 Billion TWD | 104.52% |
2019 | 1.4 Billion TWD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 9.06 Billion TWD | 80.88% |
2024 Q2 | 18.62 Billion TWD | 105.55% |
2023 Q4 | 5 Billion TWD | -26.5% |
2023 Q2 | 6.56 Billion TWD | -2.0% |
2023 Q1 | 6.69 Billion TWD | -10.95% |
2023 FY | 5 Billion TWD | -34.07% |
2023 Q3 | 6.81 Billion TWD | 3.86% |
2022 Q3 | 8.62 Billion TWD | 0.0% |
2022 Q4 | 7.52 Billion TWD | -12.77% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Grape King Bio Ltd | 192.92 Million TWD | -2496.853% |
Standard Chem & Pharm CO., LTD. | 1.08 Billion TWD | -363.017% |
Maywufa Company Ltd. | 442.66 Million TWD | -1031.744% |
ScinoPharm Taiwan, Ltd. | 621.1 Million TWD | -706.605% |
Lotus Pharmaceutical Co., Ltd. | 11.58 Billion TWD | 56.755% |
LIWANLI Innovation Co., Ltd. | 2.63 Million TWD | -189954.932% |
YungShin Global Holding Corporation | 1.23 Billion TWD | -304.207% |
PhytoHealth Corporation | 28.11 Million TWD | -17719.129% |
SCI Pharmtech, Inc. | 1.04 Billion TWD | -380.573% |
Formosa Laboratories, Inc. | 4.06 Billion TWD | -23.262% |
PharmaEssentia Corporation | 1.2 Billion TWD | -317.41% |